ANHUI HUAHENG BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121 CNY | -2.22% |
|
+2.16% | -3.91% |
| Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
| Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
ETFs positioned on Anhui Huaheng Biotechnology Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.63% | - |
Anhui Huaheng Biotechnology Co Ltd is a China-based company specializing in the research and development, production and sales of amino acids and other bio-based products based on alanine series products. The Company is a high-tech enterprise focusing on synthetic biotechnology and mainly engaged in the research and development, production and sales of amino acid and its derivative products. The Company's main products include alanine series products (L-alanine, DL-alanine, β-alanine), calcium D-pantothenate and α-arbutin. The Company's products are mainly used in the fields of medicine and health products, daily chemicals, food and food additives. The Company distributes its products and services within the domestic market and to overseas markets.
Sector
Food Processing
Calendar
2024-08-14
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
121
CNY
Average target price
135.7
CNY
Spread / Average Target
+12.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.91% | 2.63B | |
| +2.37% | 29.86B | |
| +20.02% | 24.81B | |
| +6.21% | 11.19B | |
| +18.74% | 5.44B | |
| +20.42% | 4.54B | |
| -9.27% | 3.79B | |
| +4.52% | 3.12B | |
| +29.28% | 2.86B | |
| +4.70% | 2.41B |
- Stock Market
- Equities
- 688639 Stock
- Funds and ETFs Anhui Huaheng Biotechnology Co., Ltd.